Blood levels alone cannot confirm safe testosterone dosing. Asking about androgenic effects and allowing months for response are central to care.
|Videos|October 28, 2022
Mechanistic insights into the pelvic floor shared-disease model with the AUGS Publication Committee
Sit in on a recent discussion between Gina Northington, MD, and Marianna Alperin, MD, co-editors of the ebook from AUGS and the IUA entitled, 'Pelvic Floor: Foundational Science and Mechanistic Insights for a Shared Disease Model.'
Advertisement
A recent segment from a series of interviews by the AUGS Publications Committee, this video features a discussion on the ebook Pelvic Floor: Foundational Science and Mechanistic Insights for a Shared Disease Model, from the American Urogynecologic Society (AUGS) and the International Urogynecological Association.
Gina Northington, MD, is the AUGS Board of Directors’ Publications Committee liaison and co-editor of the ebook
Marianna Alperin, MD, is the writing group chair and co-editor of the ebook.
Advertisement
Related to this article
A global consensus defines what the evidence supports for testosterone in women. Benefits for strength, mood, and cognition lack randomized data.
A testosterone patch improved sexual desire in trials but never won US approval. Normal female physiology defines what replacement should target.
The WHI never studied testosterone, yet it chilled conversations about every hormone, with lasting consequences for women’s sexual health.
As estrogen came to define menopause care, testosterone faded from view, and the oral combination clinicians relied on was never FDA approved.
Androgen therapy for women predates the headlines by decades. Early research showed promise for desire, but long-term safety data never caught up.
Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to Sameena Rahman, MD.
Samples from a large UK screening trial supported validation of the investigational Evident ovarian cancer test, according to Dawn Mattoon, PhD.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
What biomarker-guided preeclampsia care could look like
2
Testosterone for women: Global consensus and physiologic dosing
3
Testosterone physiology in women and the long road to approval
4
Testosterone in women: Androgenic adverse events and lab monitoring
5